Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Befrits
Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Php353 - Romanian Experience With Managed Entry Agreements for Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Adoption of Managed Entry Agreements in Established and Emerging Markets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
What Principles Should Govern the Use of Managed Entry Agreements?
International Journal of Technology Assessment in Health Care
Health Policy
PHP46 Market Uptake of Orphan Drugs – A European Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Managed Entry Agreements (MEA): Analysis of the Current Situation in Middle East and North Africa
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php249 - Are Traditional Managed Entry Agreements Suitable for Potentially, Curative Gene/Cell Therapies?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy135 - Access to Orphan Drugs – Regulation Within the European Law
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy188 - Use of Managed Entry Agreements in Inflammatory Disorders Among Key Health Technology Assessment Agencies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy165 - Price Differences for Orphan Drugs Across the Eu-5 Countries: A Comparative Assessment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental